Minerva Neurosciences, Inc. Stock Issued During Period, Shares, Reverse Stock Splits
Minerva Neurosciences, Inc. (NERV) had Stock Issued During Period, Shares, Reverse Stock Splits of 5.34 million shares as of 2022-06-17, per its 10-K filed 2024-02-22.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits · last filed 2024-02-22
- 2022-06-17: Stock Issued During Period, Shares, Reverse Stock Splits 5.34M shares.
- 2022-06-16: Stock Issued During Period, Shares, Reverse Stock Splits 42.72M shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits |
|---|---|
| 2022-06-17 | 5.34M shares 10-K · filed 2024-02-22 |
| 2022-06-16 | 42.72M shares 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |